Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Source BioScience mark 'eight fold in revenue for company' with 'Covid-19 business the engine'

Source BioScience mark 'eight fold in revenue for company' with 'Covid-19 business the engine'

SourceBio International PLC's (LON:SBI) Jay LeCoque talks to Proactive London's Katie Pilbeam about their 2020 results.

The company reporting strong revenue and profit growth throughout the year driven by its (Coronavirus) COVID-19 antigen testing services and its Infectious Disease Testing business unit, set up last May.

Going forward Jay says 'the Covid-19 business was the engine for the company this past year' and he does not thinking the market for testing is going to go away 'that quickly'. He says airport and sport facility testing is going to be crucial through to 2024.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK